International Consortium for Health Outcome Measurement Set of Outcomes That Matter to People Living With Inflammatory Arthritis: Consensus From an International Working Group.


Journal

Arthritis care & research
ISSN: 2151-4658
Titre abrégé: Arthritis Care Res (Hoboken)
Pays: United States
ID NLM: 101518086

Informations de publication

Date de publication:
12 2019
Historique:
received: 01 05 2018
accepted: 16 10 2018
pubmed: 26 10 2018
medline: 14 4 2020
entrez: 26 10 2018
Statut: ppublish

Résumé

The implementation of value-based health care in inflammatory arthritis requires a standardized set of modifiable outcomes and risk-adjustment variables that is feasible to implement worldwide. The International Consortium for Health Outcomes Measurement (ICHOM) assembled a multidisciplinary working group that consisted of 24 experts from 6 continents, including 6 patient representatives, to develop a standard set of outcomes for inflammatory arthritis. The process followed a structured approach, using a modified Delphi process to reach consensus on the following decision areas: conditions covered by the set, outcome domains, outcome measures, and risk-adjustment variables. Consensus in areas 2 to 4 were supported by systematic literature reviews and consultation of experts. The ICHOM Inflammatory Arthritis Standard Set covers patients with rheumatoid arthritis (RA), axial spondyloarthritis, psoriatic arthritis, and juvenile idiopathic arthritis (JIA). We recommend that outcomes regarding pain, fatigue, activity limitations, overall physical and mental health impact, work/school/housework ability and productivity, disease activity, and serious adverse events be collected at least annually. Validated measures for patient-reported outcomes were endorsed and linked to common reporting metrics. Age, sex at birth, education level, smoking status, comorbidities, time since diagnosis, and rheumatoid factor and anti-citrullinated protein antibody lab testing for RA and JIA should be collected as risk-adjustment variables. We present the ICHOM inflammatory arthritis Standard Set of outcomes, which enables health care providers to implement the value-based health care framework and compare outcomes that are important to patients with inflammatory arthritis.

Identifiants

pubmed: 30358135
doi: 10.1002/acr.23799
pmc: PMC6900179
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1556-1565

Subventions

Organisme : Arthritis Research UK
Pays : United Kingdom

Informations de copyright

© 2018, The Authors. Arthritis Care & Research published by Wiley Periodicals, Inc. on behalf of American College of Rheumatology.

Références

JAMA Oncol. 2017 May 1;3(5):686-694
pubmed: 28384684
Arthritis Rheum. 2011 Mar;63(3):633-9
pubmed: 21360492
Am J Kidney Dis. 2019 Mar;73(3):372-384
pubmed: 30579710
J Crohns Colitis. 2018 Mar 28;12(4):408-418
pubmed: 29216349
Qual Life Res. 2010 May;19(4):539-49
pubmed: 20169472
PLoS Med. 2011 Jan 25;8(1):e1000393
pubmed: 21283604
Arthritis Care Res (Hoboken). 2016 Nov;68(11):1631-1639
pubmed: 26881821
Ann Rheum Dis. 2016 Jan;75(1):16-22
pubmed: 25990290
Ann Rheum Dis. 2016 Apr;76(4):673-680
pubmed: 27613807
Ann Rheum Dis. 2014 Jul;73(7):1316-22
pubmed: 24550173
Am J Ophthalmol. 2016 Aug;168:1-12
pubmed: 27131774
Cleft Palate Craniofac J. 2017 Sep;54(5):540-554
pubmed: 27223626
JAMA Oncol. 2017 May 1;3(5):677-685
pubmed: 28033439
Best Pract Res Clin Rheumatol. 2008 Aug;22(4):621-41
pubmed: 18783741
Int Urogynecol J. 2017 Dec;28(12):1785-1793
pubmed: 28948362
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S1-3
pubmed: 22588738
Rheumatology (Oxford). 2017 Jan;56(1):4-5
pubmed: 27012689
Arthritis Rheum. 1997 Jul;40(7):1202-9
pubmed: 9214419
J Parkinsons Dis. 2017;7(3):533-543
pubmed: 28671140
Acta Orthop. 2016 Feb;87(1):88
pubmed: 26610164
Eur Respir J. 2016 Sep;48(3):852-60
pubmed: 27390281
N Engl J Med. 2016 Feb 11;374(6):504-6
pubmed: 26863351
J Am Heart Assoc. 2015 May 19;4(5):null
pubmed: 25991011
BMC Geriatr. 2018 Feb 2;18(1):36
pubmed: 29394887
Ann Rheum Dis. 2010 Apr;69(4):631-7
pubmed: 20215140
Arthritis Rheumatol. 2016 Jan;68(1):1-26
pubmed: 26545940
J Clin Epidemiol. 2007 Jan;60(1):34-42
pubmed: 17161752
J Rheumatol. 1997 Nov;24(11):2225-9
pubmed: 9375888
Arthritis Rheum. 1993 Jun;36(6):729-40
pubmed: 8507213
Ann Rheum Dis. 2014 Jan;73(1):238-42
pubmed: 23740234
Eur Urol. 2015 Nov;68(5):891-8
pubmed: 26129856
Qual Life Res. 2019 Jan;28(1):187-197
pubmed: 30317425
N Engl J Med. 2010 Dec 23;363(26):2477-81
pubmed: 21142528
Arthritis Care Res (Hoboken). 2015 May;67(6):865-72
pubmed: 25186344
Qual Life Res. 2017 Dec;26(12):3211-3225
pubmed: 28786017
JAMA Ophthalmol. 2015 Nov;133(11):1247-52
pubmed: 26291752
Qual Life Res. 2013 Oct;22(8):1889-905
pubmed: 23288613
Stroke. 2016 Jan;47(1):180-6
pubmed: 26604251
Eur Urol. 2015 Mar;67(3):460-7
pubmed: 25234359

Auteurs

Martijn A H Oude Voshaar (MAH)

University of Twente, Enschede, The Netherlands.

Zofia Das Gupta (Z)

International Consortium for Health Outcomes Measurement, London, UK.

Johannes W J Bijlsma (JWJ)

University Medical Center Utrecht, Utrecht, The Netherlands.

Annelies Boonen (A)

Maastricht University Medical Centre, Maastricht, The Netherlands.

Jeffrey Chau (J)

Hong Kong Psoriatic Arthritis Association, Hong Kong, China.

Delphine S Courvoisier (DS)

University Hospitals of Geneva and University of Geneva, Geneva, Switzerland.

Jeffrey R Curtis (JR)

University of Alabama at Birmingham.

Benjamin Ellis (B)

Imperial College Healthcare NHS Trust, London, UK.

Sofia Ernestam (S)

Karolinska Institutet, Stockholm, Sweden.

Laure Gossec (L)

Sorbonne Université and Pitié Salpêtrière Hospital, AP-HP, Paris, France.

Christine Hale (C)

Lockton Dunning Benefits, Dallas, Texas.

Jennifer Hornjeff (J)

Columbia University Medical Centre, New York, New York.

Katy Y Y Leung (KYY)

Singapore General Hospital, Duke-NUS Medical School, Singapore.

Merav Lidar (M)

Sheba Medical Centre, Tel-Hashomer, Israel.

Phillip Mease (P)

Providence St. Joseph Health System, University of Washington, Seattle.

Kaleb Michaud (K)

University of Nebraska Medical Center Omaha, and the National Databank for Rheumatic Diseases, Wichita, Kansas.

Girish M Mody (GM)

University of KwaZulu-Natal, Durban, South Africa.

Mwidimi Ndosi (M)

University of the West of England, Bristol, UK.

Christina H Opava (CH)

Karolinska Institutet, Stockholm, Sweden.

Geraldo R C Pinheiro (GRC)

Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.

Matthew Salt (M)

International Consortium for Health Outcomes Measurement, London, UK.

Enrique R Soriano (ER)

Instituto Universitario Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

William J Taylor (WJ)

University of Otago, Wellington, New Zealand.

Maria J H Voshaar (MJH)

University of Twente, Enschede, The Netherlands.

Angelique E A M Weel (AEAM)

Maasstad Hospital, Rotterdam, The Netherlands.

Maarten de Wit (M)

VU University Medical Centre, Amsterdam Public Health, Amsterdam, The Netherlands.

Nico Wulffraat (N)

Wilhelmina Children's Hospital, Utrecht, The Netherlands.

Mart A F J van de Laar (MAFJ)

University of Twente, Enschede, The Netherlands, and International Consortium for Health Outcomes Measurement, London, UK.

Harald E Vonkeman (HE)

University of Twente, Enschede, The Netherlands, and International Consortium for Health Outcomes Measurement, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH